Anticorps Recombinant de lapin anti-CCL22/MDC

CCL22/MDC Recombinant Antibody for FC (Intra)

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

FC (Intra)

Conjugaison

Non conjugué

CloneNo.

241668D5

N° de cat : 98280-1-RR

Synonymes

CCL22, MDC, ccl 22, C-C motif chemokine 22, CC chemokine STCP-1



Applications testées

Résultats positifs en FC (Intra)human monocyte-derived mature dendritic cells

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

98280-1-RR cible CCL22/MDC dans les applications de FC (Intra) et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Protéine recombinante
Nom complet chemokine (C-C motif) ligand 22
Masse moléculaire calculée 93 aa, 11 kDa
Numéro d’acquisition GenBankBC027952
Symbole du gène CCL22/MDC
Identification du gène (NCBI) 6367
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Protein A purfication
Tampon de stockage PBS with 0.09% sodium azide
Conditions de stockageStore at 2 - 8°C. Stable for one year after shipment.

Informations générales

The C-C motif chemokine ligand 22 (CCL22), also known as MDC, belongs to the group of chemokines, that are both constitutively expressed under homeostatic conditions and inducible upon inflammation. CCL22 is a secreted protein that exerts chemotactic activity for monocytes, dendritic cells, natural killer cells, and for chronically activated T lymphocytes. CCL22 is induced by LPS, IL-4, and IL-13 and in T cells by TCR stimulation. Accumulating studies indicate that CCL22 recruits regulatory T (T-reg) cells into tumor tissues and is expressed in many human tumors.

Protocole

Product Specific Protocols
FC protocol for CCL22/MDC antibody 98280-1-RRDownload protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}